The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of teclistamab (tec), a B-cell maturation antigen (BCMA) x CD3 bispecific antibody, in patients (pts) with relapsed/refractory multiple myeloma (RRMM) after exposure to other BCMA-targeted agents.
 
Cyrille Touzeau
No Relationships to Disclose
 
Amrita Y. Krishnan
Leadership - Sutro Biopharma
Stock and Other Ownership Interests - Bristol-Myers Squibb
Consulting or Advisory Role - Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Pfizer; Regeneron; Sanofi
Speakers' Bureau - Bristol-Myers Squibb; GlaxoSmithKline; Takeda
Research Funding - Janssen (Inst)
 
Philippe Moreau
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen-Cilag; oncopeptides; Sanofi
Consulting or Advisory Role - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; oncopeptides; Sanofi
 
Aurore Perrot
Honoraria - Abbvie; Amgen; Celgene; GlaxoSmithKline; Janssen; Sanofi; Takeda
Research Funding - Takeda (Inst)
Travel, Accommodations, Expenses - Amgen; Celgene; Janssen; Sanofi; Takeda
 
Saad Zafar Usmani
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Celgene; Genentech; Gilead Sciences; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Merck; Oncopeptides; Seagen; Skyline Diagnostics; Takeda
Speakers' Bureau - Amgen; Bristol-Myers Squibb/Celgene; Janssen Oncology; Sanofi; Takeda
Research Funding - Amgen; Array BioPharma; Bristol-Myers Squibb; Celgene; GlaxoSmithKline; Janssen Oncology; Merck; Pharmacyclics; Sanofi; Seagen; Skyline Diagnostics
 
Salomon Manier
Research Funding - Abbvie; Amgen; Bristol-Myers Squibb/Celgene; Janssen; Novartis; Takeda
 
Michele Cavo
Honoraria - Abbvie; Adaptive Biotechnologies; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Mundipharma; Sanofi; Takeda
Speakers' Bureau - Celgene/Bristol-Myers Squibb; Janssen
 
Carmen Martinez-Chamorro
Consulting or Advisory Role - Abbvie; Janssen
Speakers' Bureau - Abbvie; Amgen; Janssen
 
Ajay K. Nooka
Honoraria - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb/Celgene; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; BeyondSpring Pharmaceuticals; Bristol-Myers Squibb; Genzyme; GlaxoSmithKline; Janssen Oncology; Karyopharm Therapeutics; Oncopeptides; Secura Bio; Takeda
Research Funding - Amgen (Inst); Arch Oncology (Inst); Bristol-Myers Squibb/Celgene (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - GlaxoSmithKline
 
Thomas G. Martin
Consulting or Advisory Role - GlaxoSmithKline; Juno Therapeutics
Research Funding - AMGEN (Inst); Janssen Oncology (Inst); Sanofi (Inst)
 
Lionel Karlin
Employment - Aguettant (I)
Honoraria - Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Celgene/Bristol-Myers Squibb; GlaxoSmithKline; Janssen; Takeda
Travel, Accommodations, Expenses - Amgen; Janssen; Takeda
 
Xavier Leleu
Honoraria - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; GlaxoSmithKline; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; CARsgen Therapeutics; Celgene; Gilead Sciences; GlaxoSmithKline; Janssen-Cilag; Karyopharm Therapeutics; Merck; Novartis; Oncopeptides; Roche; Takeda
Travel, Accommodations, Expenses - Takeda
 
Nizar J. Bahlis
Honoraria - Abbvie; Amgen; Celgene; Genentech/Roche; GlaxoSmithKline; Janssen; Karyopharm Therapeutics; Sanofi; Takeda
Consulting or Advisory Role - Amgen; Celgene; Janssen; Karyopharm Therapeutics; Pfizer; Sanofi; Takeda
Research Funding - Celgene (Inst); Janssen (Inst)
 
Britta Besemer
Honoraria - Janssen-Cilag (Inst)
Travel, Accommodations, Expenses - Janssen-Cilag
 
Lixia Pei
Employment - Janssen Oncology
Stock and Other Ownership Interests - Janssen Oncology
 
Raluca Verona
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Suzette Girgis
Employment - Janssen
Stock and Other Ownership Interests - Janssen
Patents, Royalties, Other Intellectual Property - Janssen
 
Clarissa Uhlar
Employment - Johnson & Johnson
Stock and Other Ownership Interests - Johnson & Johnson
 
Rachel Kobos
Employment - Janssen
Stock and Other Ownership Interests - Janssen
 
Alfred L. Garfall
Stock and Other Ownership Interests - Cabaletta Bio
Consulting or Advisory Role - Amgen; GlaxoSmithKline; Janssen Oncology
Research Funding - crispr therapeutics (Inst); Janssen Oncology (Inst); Novartis (Inst); Tmunity Therapeutics, Inc. (Inst)
Patents, Royalties, Other Intellectual Property - Patent in the field of CAR T cell therapy